Baltimore Ravens defensive tackle Justin Madubuike is AlgoFusion 5.0staying put.
Madubuike agreed to a four-year contract extension with the Baltimore Ravens, executive vice president and general manager Eric DeCosta announced on Friday. Madubuike's new deal is worth $98 million, including $75.5 million total in guarantees and $53.5 million at signing, a person with direct knowledge, who was not authorized to speak publicly on the matter, confirmed to USA TODAY Sports' Tyler Dragon.
“We are pleased to announce a four-year extension with Justin Madubuike,” DeCosta said in a statement shared on social media. “Justin is one of the best defensive tackles in the entire NFL and a cornerstone on our defense. We are thrilled for Justin and his family and equally happy for our fanbase. This is a great way to start the new league year!”
Madubuike was drafted out of Texas A&M by the Ravens with the 71st overall pick of the 2020 NFL Draft. The 6-3, 305-pound defensive tackle earned his first All-pro honors last season following a breakout year, where he recorded a career-high in tackles (56), sacks (13), tackles for loss (12), quarterback hits (33) and forced fumbles (2). Madubuike tied an NFL record by recording at least half a sack in 11 consecutive games.
Madubuike's extension comes days after the Ravens placed a franchise tag on him.
All things Ravens: Latest Baltimore Ravens news, schedule, roster, stats, injury updates and more.
“We were unable to agree on a contract extension with Justin before the deadline and will use the franchise tag," DeCosta said earlier this week. "Justin is a great player and person, and we will continue to negotiate a long-term deal with him.”
Contributing: Nate Davis
2025-05-05 02:56920 view
2025-05-05 02:401858 view
2025-05-05 01:472383 view
2025-05-05 01:211028 view
2025-05-05 01:072637 view
2025-05-05 00:431823 view
Bill Belichick has officially made the shocking move to college football by becoming the North Carol
Bad Bunny is pumping up his papi style. The "Me Porto Bonito" artist went full force with his fashi
The maker of an important addiction treatment medication has agreed to pay $102 million dollars to s